✨ Free AI Report
China Pharma Holdings, Inc.: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Company Research China Pharma Holdings, Inc.
Company Research

China Pharma Holdings, Inc.: Business Overview, Financials & Competitive Analysis

China Pharma Holdings, Inc. scores 2/10 on the AskCyborg Cyborg Score (Challenged). Distressed micro-cap with significant regulatory and financial stress; unlikely to generate shareholder returns near term. China Pharma faces severe operational and financial headwinds. Substantial stock price deterioration (78% decline in one year as of March 2026), multiple NYSE American compliance deficiency notices, and sparse positive developments signal distressed.

What is China Pharma Holdings, Inc.'s industry? China Pharma Holdings, Inc. (chinapharma.com.cn) operates in Pharmaceuticals. AskCyborg classifies China Pharma Holdings, Inc. under Pharmaceuticals in its company registry.

China Pharma Holdings is a fully-integrated specialty pharmaceuticals company in China. The company is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for high-incidence and hi...

2/ 10Challenged

Cyborg Score thesis

Distressed micro-cap with significant regulatory and financial stress; unlikely to generate shareholder returns near...

Read the full analyst-debate transcript →
Industry Pharmaceuticals
3 named competitors
3 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: September 28, 2026
AI-Verified Research
30+ Page Report

Get the Latest China Pharma Holdings, Inc. Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Analyst-debate audio for China Pharma Holdings, Inc.

AskCyborg analysts argue the bull and bear cases for China Pharma Holdings, Inc. across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
What's in This Report
China Pharma Holdings, Inc. OverviewStrategic ProfileCompetitive LandscapeIndustry ContextKey facts
Get Interactive Report Freeor start reading below

China Pharma Holdings, Inc. Overview

Pro stress-test →

China Pharma Holdings is a fully-integrated specialty pharmaceuticals company in China. The company is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for high-incidence and high-mortality diseases and medical conditions prevalent in the PRC.

Strategic Profile

Pro stress-test →

The company's products include dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The company operates with limited financial visibility and faces significant stock price volatility; the share price declined from $2.90 in March 2025 to $0.63 in March 2026, representing a 78.29% decline.

Competitive Landscape

Pro stress-test →

China Pharma competes in the generic and branded pharmaceutical market in China against established domestic and international pharmaceutical companies. The company focuses on specialty products for high-incidence diseases, but faces intense competition from larger, better-capitalized competitors with broader product portfolios and stronger distribution networks.

Industry Context

China Pharma Holdings, Inc. operates in Pharmaceuticals.

Key facts

Founded: N/A · Headquarters: Haikou, China · Employees: N/A · Revenue: N/A · Market cap: N/A

What the analysts stress-tested

The top findings that survived the multi-agent debate for China Pharma Holdings, Inc..

  • (March 2026) Stock price collapsed 78% year-over-year, falling from $2.90 to $0.63 per share
  • (January 2026) Stockholders approved reverse stock split and governance changes
+2 more stress-tested counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

  • May 2026NYSE American inquired about unusual market activity; company disclosed no material nonpublic information
  • January 2026Stockholders approved reverse stock split and governance changes
  • +1 moreTrack every material event for China Pharma Holdings, Inc. as it happens. Explore monitoring →
Get alerted when China Pharma Holdings, Inc. has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

Generic PharmaceuticalsChina's largest pharmaceutical producer and distributor→Branded PharmaceuticalsSpecialty pharmaceutical manufacturer in China→Specialty InjectablesChinese injectable pharmaceutical manufacturer→

Compare China Pharma Holdings, Inc. with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

China Pharma Holdings, Inc. operates in Pharmaceuticals. See how the rest of the sector scores on the Cyborg framework.

Browse Pharmaceuticals research →
NEW · MCP server

Ask your AI assistant about China Pharma Holdings, Inc.

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare China Pharma Holdings, Inc. and its top competitor on Cyborg Score”
“What did China Pharma Holdings, Inc. do this quarter?”
“Is China Pharma Holdings, Inc. a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg builds confidence

⚔

Analyst debate, not single-author opinion

Every report is stress-tested by a panel of AI analysts arguing across 11 dimensions. The output is the part of the case that survived pushback.

📊

Recalibrated weekly

The Cyborg Score is recomputed weekly against fresh data. Recent material developments are continuously tracked and surfaced.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The same company gets the same score from any analyst running the framework.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, news flow, and proprietary analyst signals. Read the methodology →

Frequently asked questions

What does China Pharma Holdings, Inc. do?+
China Pharma Holdings is a fully-integrated specialty pharmaceuticals company in China. The company is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for high-incidence and hi...
What is China Pharma Holdings, Inc.'s Cyborg Score?+
China Pharma Holdings, Inc. has a Cyborg Score of 2/10 (Challenged). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are China Pharma Holdings, Inc.'s main competitors?+
Named competitors include Generic Pharmaceuticals, Branded Pharmaceuticals, Specialty Injectables. The full competitive landscape is in the AskCyborg report.
How can I get the full China Pharma Holdings, Inc. research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the China Pharma Holdings, Inc. research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track China Pharma Holdings, Inc. over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

More Pharmaceuticals research

Companies in the same sector and named competitors, ranked by Cyborg Score.

7Novartis AG7Recordati Industria Chimica e Farmaceutica SpA6CSPC Innovation Pharmaceutical Co., Ltd.